• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Chiron Recombinant Proteins

    Syngene International Ltd.

    BioIVT

    Lannett CDMO

    INCOG BioPharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Chiron Recombinant Proteins

    Syngene International Ltd.

    BioIVT

    Lannett CDMO

    INCOG BioPharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    3P Biopharmaceuticals Completes Facility Expansion

    Investment exceeds €5 million

    Related CONTENT
    • Biosynth
    • Corden Pharma
    • MedPharm
    • Coriolis Pharma
    • 3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
    12.26.18
    3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in the process development and GMP production of biologics, has completed the project for the expansion and improvement of its facilities in Noáin, Spain that had been carried out over the past few months. The investment exceeded the €5 million in addition to the €8 million that 3P has invested since 2013.
     
    The new facility design is part of the company’s strategic plan designed to position 3P as a an international CDMO. This project has equipped 3P with new capacities and capabilities to meet the growing demands of the market and the needs of its current clients, with some of their processes already in commercial stages. In addition, 3P has incorporated technology and equipment to obtain greater competitiveness in this highly demanding market. 
     
    The new facilities have been GMP-certified by the AEMPS (The Spanish Agency of Medicines and Medical Devices).
     
    As part of this recent project, 3P has built segregated new areas equipped with specific equipment for the culture of microbial and mammalian cells. These facilities allow 3P to develop different processes simultaneously. 

    The process development area has been equipped with aninnovative air handling design that is similar design to the one used in its GMP manufacturing plant. This minimizes the risk of cross-contamination during the execution of different simultaneous experiments. 

    Also noteworthy is the acquisition of a single-use multi-parallel bioreactor—ambr 250—that together with other analytic equipment, have required an investment of almost €1 million. The ambr 250 allows 3P to develop 24 different experiments concurrently. This capacity facilitates rapid decision-making for future manufacturing processes. In addition, this technology strengthens the capacity of 3P to carry out process characterization activities, an essential phase to drive the drug to the market.  

    The expansion of the GMP manufacturing area has focused on the amplification of the bacterial area. Thus, allowing 3P to transfer in and manufacture such products at different stages of their development. The mammalian cell culture area has been enhanced thanks to the acquisition of a new 50 L single use bioreactor. This provides an option for small-scale batch manufacture as well as for intermediate cell expansion. 

    3P is also making investment efforts to improve data management in the analytical areas including development and QC by incorporating LIMS technology (Laboratory Information Management Systems). LIMS is a comprehensive solution that improves quality and safety throughout the entire product lifecycle: from sample intake to the delivery of accurate results, driving smarter decisions throughout the entire process. It also optimizes data management, accessibility, traceability, integrity and long-term value. 

    The analytical area has been also equipped with state-of-the-art technologies including mass spectrometry, chromatography equipment, bioanalytical analyzers and a Maurice system (Protein Simple). All these technologies allow the rapid determination of identity, purity and characterization of proteins with a higher precision. 

    This Project specific to facility growth and adaptation, has been accompanied with an important increase in human resource. During 2018, more than 50 professionals have joined the company and is expected to exceed the 245 personnel forecasts for 2019. 

    Damaso Molero, general manager at 3P, said, “This investment is consolidating the important successes we have achieved with our clients, with two of their products already in commercial stages. We have no doubts that our capacity and knowledge in mammalian cell culture will allow us to compete in this important market.” 
    Related Searches
    • expansion
    • Bioanalytical
    • Process Development
    • data management
    Suggested For You
    Biosynth Biosynth
    Corden Pharma Corden Pharma
    MedPharm MedPharm
    Coriolis Pharma Coriolis Pharma
    3P and Buzzard Pharmaceuticals Enter Cancer Collaboration 3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
    Groupe Parima Groupe Parima
    3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement 3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement
    3P Expands Management Team 3P Expands Management Team
    Softweb Solutions Softweb Solutions
    Zile Bonbons Zile Bonbons
    Vetio Animal Health Vetio Animal Health
    Siegfried Irvine Siegfried Irvine
    Injectables Go Deeper Injectables Go Deeper
     Dedicated to Excellence Dedicated to Excellence
    Market on the Rise: Parenterals Market on the Rise: Parenterals

    Related Buyers Guide Companies

    • Biosynth

      Biosynth

      ...
      Aimee Cossins, Marketing 11.08.22

    • APIs | Injectables
      Corden Pharma

      Corden Pharma

      ...
      Abby Thompson, Global Marketing Communications Manager 12.02.21

    • MedPharm

      MedPharm

      ...
      Andie Woodson, Marketing Manager 10.21.21


    • Coriolis Pharma

      Coriolis Pharma

      ...
      Bettina von Klitzing-Stu00fcckle 07.01.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

      3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

      Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.
      Charles Sternberg, Assistant Editor 05.07.21

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login